| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/ICO.0B013E3181F7F363 |
| P698 | PubMed publication ID | 21045640 |
| P2093 | author name string | Junhua Yu | |
| Carol J Fairchild | |||
| Carl V Asche | |||
| P433 | issue | 4 | |
| P921 | main subject | United States of America | Q30 |
| eye disease | Q3041498 | ||
| P304 | page(s) | 379-387 | |
| P577 | publication date | 2011-04-01 | |
| P1433 | published in | Cornea | Q15760110 |
| P1476 | title | The economic burden of dry eye disease in the United States: a decision tree analysis | |
| P478 | volume | 30 |
| Q41442733 | A comparative review of Haute Autorité de Santé and National Institute for Health and Care Excellence health technology assessments of Ikervis® to treat severe keratitis in adult patients with dry eye disease which has not improved despite treatment |
| Q91906669 | A comparative study of the quality of non-stimulated and stimulated tears in normal eye male subjects using the tear ferning test |
| Q33837188 | A novel TRPM8 agonist relieves dry eye discomfort |
| Q38001489 | A review of the complications of lacrimal occlusion with punctal and canalicular plugs |
| Q91639178 | Acupoint selection for the treatment of dry eye: A systematic review and meta-analysis of randomized controlled trials |
| Q34277339 | Acupuncture for the treatment of dry eye: a multicenter randomised controlled trial with active comparison intervention (artificial teardrops). |
| Q92442286 | Advances in dry eye disease treatment |
| Q35773063 | Age-related Defects in Ocular and Nasal Mucosal Immune System and the Immunopathology of Dry Eye Disease |
| Q34114336 | Aging: a predisposition to dry eyes. |
| Q37276546 | Agreement of noninvasive tear break-up time measurement between Tomey RT-7000 Auto Refractor-Keratometer and Oculus Keratograph 5M. |
| Q57814418 | An Eyelid Warming Device for the Management of Meibomian Gland Dysfunction |
| Q34043708 | Androgen deficiency and dry eye syndrome in the aging male |
| Q33713187 | Association of dry eye disease with psychiatric or neurological disorders in elderly patients |
| Q26781979 | Associations between signs and symptoms of dry eye disease: a systematic review |
| Q38160064 | Bepotastine besilate for the treatment of pruritus |
| Q38712838 | Burning Eye Syndrome: Do Neuropathic Pain Mechanisms Underlie Chronic Dry Eye? |
| Q90746682 | Changes in Corneal Detection Thresholds After Repeated Tear Film Instability |
| Q39960842 | Characteristics of Ocular Pain Complaints in Patients With Idiopathic Dry Eye Symptoms. |
| Q98613385 | Climatic and Environmental Correlates of Dry Eye Disease Severity: A Report From the Dry Eye Assessment and Management (DREAM) Study |
| Q37187277 | Comparison of two methods for composite score generation in dry eye syndrome |
| Q91811467 | Contribution of Mucins towards the Physical Properties of the Tear Film: A Modern Update |
| Q34305185 | Cost of dry eye treatment in an Asian clinic setting |
| Q37562454 | Cost-Effectiveness Analysis of Isavuconazole vs. Voriconazole as First-Line Treatment for Invasive Aspergillosis |
| Q57378488 | Current and emerging therapy of dry eye disease. Part A: pharmacological modalities |
| Q35570541 | Cyclosporine ophthalmic emulsions for the treatment of dry eye: a review of the clinical evidence |
| Q92465209 | Defining the needs and preferences of patients with dry eye disease |
| Q37536295 | Discordant Dry Eye Disease (An American Ophthalmological Society Thesis). |
| Q57171838 | Dry Eye Assessment and Management (DREAM©) Study: Study design and baseline characteristics |
| Q92824372 | Dry Eye Disease: A Review of Epidemiology in Taiwan, and its Clinical Treatment and Merits |
| Q34346990 | Dry Eye Disease: Impact on Quality of Life and Vision |
| Q61802909 | Dry eye disease ranking among common reasons for seeking eye care in a large US claims database |
| Q47639135 | Dry eye syndrome: developments and lifitegrast in perspective |
| Q26770830 | Economic and Humanistic Burden of Dry Eye Disease in Europe, North America, and Asia: A Systematic Literature Review |
| Q99237751 | Effect of Dry Eye Disease on the Kinetics of Lacrimal Gland Dendritic Cells as Visualized by Intravital Multi-Photon Microscopy |
| Q37163760 | Efficacy of an artificial tear emulsion in patients with dry eye associated with meibomian gland dysfunction |
| Q38102006 | Emerging drugs for the treatment of dry eye disease |
| Q90182784 | Engineered metal oxide nanomaterials inhibit corneal epithelial wound healing in vitro and in vivo |
| Q92507140 | Evaluating Patient Experiences in Dry Eye Disease Through Social Media Listening Research |
| Q40039054 | Gaps in Current Knowledge and Priorities for Future Research in Dry Eye. |
| Q33686417 | Image-guided evaluation and monitoring of treatment response in patients with dry eye disease |
| Q41350375 | Incomplete response to artificial tears is associated with features of neuropathic ocular pain. |
| Q93137705 | Lifitegrast: a novel drug for patients with dry eye disease |
| Q36469760 | Longitudinal evidence on punctal plug use in an elderly population |
| Q34352348 | Lost to follow-up for appointments in a dedicated dry eye clinic |
| Q58887349 | Machine Learning Applied to Optometry Data |
| Q47442388 | Modern Therapeutic Approaches for Noninfectious Ocular Diseases Involving Inflammation. |
| Q35196826 | Neuropathic ocular pain: an important yet underevaluated feature of dry eye. |
| Q37551864 | Ocular surface symptoms in veterans returning from operation Iraqi freedom and operation enduring freedom |
| Q36931629 | Oral supplementation with a nutraceutical formulation containing omega-3 fatty acids, vitamins, minerals, and antioxidants in a large series of patients with dry eye symptoms: results of a prospective study |
| Q58611982 | Osteoporosis and dry eye syndrome: A previously unappreciated association that may alert active prevention of fall |
| Q52608828 | Patient and physician perspectives on the use of cyclosporine ophthalmic emulsion 0.05% for the management of chronic dry eye. |
| Q42110795 | Periocular and intra-articular injection of canine adipose-derived mesenchymal stem cells: an in vivo imaging and migration study |
| Q35221293 | Polycystin-2 expression and function in adult mouse lacrimal acinar cells |
| Q38918702 | Prevalence of Dry Eye in Uyghur and Han Ethnic Groups in Western China |
| Q37110777 | Proteomics analysis of human tears from aqueous-deficient and evaporative dry eye patients |
| Q52661549 | Reflections on Dry Eye Syndrome Treatment: Therapeutic Role of Blood Products. |
| Q36812082 | Small-molecule CFTR activators increase tear secretion and prevent experimental dry eye disease |
| Q38674125 | Surface Chemistry Interactions of Cationorm with Films by Human Meibum and Tear Film Compounds |
| Q97529840 | Symptoms of ocular surface disease in construction workers: comparative study with office workers |
| Q47138569 | TRI Microspheres prevent key signs of dry eye disease in a murine, inflammatory model. |
| Q37409792 | Tear lipid layer thickness with eye drops in meibomian gland dysfunction |
| Q38088007 | TearLab® Osmolarity System for diagnosing dry eye. |
| Q36989827 | The Association between Symptoms of Dry Eye Syndrome and Metabolic Outcome in a General Population in Korea |
| Q91761542 | The Innate Immune Cell Profile of the Cornea Predicts the Onset of Ocular Surface Inflammatory Disorders |
| Q48344821 | The Use of Topical Corticosteroids for Treatment of Dry Eye Syndrome. |
| Q39132630 | The cost-effectiveness of HLA-B*5801 screening to guide initial urate-lowering therapy for gout in the United States |
| Q28083825 | The pathophysiology, diagnosis, and treatment of dry eye disease |
| Q50110517 | Therapeutic inhibitors for the treatment of dry eye syndrome. |
| Q37721598 | Tissue resident memory T cells in the human conjunctiva and immune signatures in human dry eye disease |
| Q34206399 | Topical interleukin 1 receptor antagonist for treatment of dry eye disease: a randomized clinical trial. |
| Q38787674 | Treg-recruiting microspheres prevent inflammation in a murine model of dry eye disease. |
| Q92407257 | Trends in licence approvals for ophthalmic medicines in the United Kingdom |
| Q28066928 | Turning Down the Thermostat: Modulating the Endocannabinoid System in Ocular Inflammation and Pain |
| Q60946811 | What's new in dry eye disease diagnosis? Current advances and challenges |
| Q90173270 | [Intense pulsed light (IPL) as a therapeutic option for Meibomian gland dysfunction] |
| Q88350776 | n-3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease |
Search more.